Ginkgo Bioworks Holdings (DNA) Net Margin (2020 - 2026)

Ginkgo Bioworks Holdings has reported Net Margin for 7 years, with the latest figure at 33.52% in Q1 2026.

• For the quarter ending Q1 2026, Net Margin fell 1352.0% year-over-year to 33.52%; the trailing twelve-month figure through Mar 2026 stood at 161.58% (up 943.0% YoY), and the FY2025 full-year result was 183.81%, up 5713.0% from the prior year.
• Net Margin for Q1 2026 stood at 33.52%, up from 241.8% in the prior quarter.
• The five-year high for Net Margin was 20.0% in Q1 2025, with the low at 1009.26% in Q3 2022.
• Historically, Net Margin has averaged 316.55% across 5 years, with a median of 245.25% in 2024.
• The largest YoY upside for Net Margin was 90475 bps in 2022 against a maximum downside of 87732 bps in 2022.
• Ginkgo Bioworks Holdings' Net Margin stood at 176.1% in 2022, then slumped by 246 bps to 609.1% in 2023, then jumped by 60 bps to 245.25% in 2024, then rose by 1 bps to 241.8% in 2025, then soared by 86 bps to 33.52% in 2026.
• The last three Net Margin figures came in at 33.52% (Q1 2026), 241.8% (Q4 2025), and 207.93% (Q3 2025), per Business Quant data.